Skip to main content
Clinical Trials/NCT01876199
NCT01876199
Completed
Not Applicable

Targeted Screening of At-Risk Adults for Acute HIV-1 Infection

University of Oxford1 site in 1 country522 target enrollmentFebruary 2013
ConditionsHIV

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV
Sponsor
University of Oxford
Enrollment
522
Locations
1
Primary Endpoint
Difference in Number and proportion of adults responding to standard appointment versus intense follow up.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

In this research, the investigators want to see if early detection of HIV infection can be improved by testing young adults who seek urgent health care from pharmacies and healthcare facilities with symptoms similar to those people get with recent HIV infection.

Specific objectives:

  1. What proportion of people presenting with these symptoms are HIV positive at the point of seeking urgent health care?
  2. What proportion of those who test negative or where the result is unclear (one rapid test positive and one negative) at first rapid HIV testing, will test positive two weeks later?
  3. What is the best way (SMS, phone call or home visit) to remind people to come for the second test after two weeks?
  4. Will young adults who seek urgent health care for fever, body pains, diarrhoea or an STD from pharmacies or health facilities find it acceptable to be invited for an HIV-1 test at the time of health care seeking?

Hypotheses

  1. Targeted screening for AHI among patients seeking health care for symptoms compatible with AHI or sexually transmitted disease (STD) will identify AHI cases in more than 1% of those screened.
  2. Intense follow-up of patients evaluated for AHI will improve rates of repeat HIV-1 testing 2-4 weeks after initial health-care seeking, relative to standard practice (i.e., recommendation to return for testing on a given date).
Registry
clinicaltrials.gov
Start Date
February 2013
End Date
July 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • symptom score of 2 or more: Confirmed fever (≥37.5 °C axillary), reported diarrhoea, or evidence of STD (variable score=2); reported body pains, or report of more than one sexual partners in past 2 months (variable score=1)
  • resident in Mtwapa or Shanzu or planning to stay in Mtwapa for approximately 4 weeks duration
  • willing to give locator information (including mobile phone number)
  • negative or unknown HIV status

Exclusion Criteria

  • patients not meeting inclusion criteria

Outcomes

Primary Outcomes

Difference in Number and proportion of adults responding to standard appointment versus intense follow up.

Time Frame: 2 weeks

Secondary Outcomes

  • Number and proportion of adults diagnosed with AHI by rapid antibody seroconversion.(2 weeks)

Study Sites (1)

Loading locations...

Similar Trials